Sphygmocor XCEL the device they are selling to the clinical practice market is priced at 14,000 US , all its competitors are priced much lower . Do you see clinical practices buying the most expensive unit. The lowest competitor is 1/3 the cost of XCEL and will also have the CPT 1 code early next year they mention. ACG currently priced at $46m mainly because one investor bought up and has now gone conspicuously under 5% holding. I do hope the sales turn up and will be waiting for confirmation.
Ann: App 4E / Full Year Statutory Accounts, page-7
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CDX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.35M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 14197 | 5.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.0¢ | 9803 | 1 |
View Market Depth
| Last trade - 16.12pm 27/09/2024 (20 minute delay) ? |
| CDX (ASX) Chart |
Day chart unavailable